International Colloquium on Hyperemesis Gravidarum 2019
The ICHG organisations and Stichting ZEHG are proud to present the 3rd International Colloquium on Hyperemesis Gravidarum, ICHG 2019.
Bringing together the world’s leading researchers in hyperemesis gravidarum this two day event, in the heart of Amsterdam will be an excellent opportunity for delegates to hear about the latest research developments and innovative treatments for this complex condition.
Presentations:
WELCOME ADDRESS AND OPENING OF CONFERENCE - DR REBECCA PAINTER
ICHG - A Vision for International Collaboration and Patient Inclusion - Caitlin Dean
Keynote: How to develop and change disease definitions - Patrick Bossuyt
Developing an International Definition for HG research - Iris Grooten
Determinants of disease course and severity in HG - Rebecca Painter
Does the placenta and appetite hormone GDF15 cause NVP and HG? - Marlena Fejzo
Genomic studies of severe hyperemesis gravidarum in the UK - Catherine Williamson
GDF15. What is it and why might it be involved in Nausea and Vomiting of Pregnancy? - Stephen O’Rahilly
Core Outcomes for Hyperemesis Research - Larissa Jansen
EMPOWER - Secondary care treatment for severe nausea and vomiting in pregnancy - Cath MacParlin
Transdermal clonidine for severe HG - Aldo Maina
Wernicke's encephalopathy in hyperemesis gravidarum – Erik Oudman
Need of medical care due to hyperemesis gravidarum in different pregnancy outcomes – Miina Nurmi
Implementing guidelines in Ireland - Brian Cleary
Ketones! - Rebecca Painter
Testing a cognitive model to predict posttraumatic stress disorder in women following experiences of Hyperemesis Gravidarum - Helen Penny
The impact of Hyperemesis Gravidarum on mother-child attachment and parenting stress up to two years’ postpartum: a cross-sectional study - Helen Penny
Nausea and Vomiting of Pregnancy is associated with poor sleep quality - Linda Laitinen
Nausea and vomiting during pregnancy genetics consortium - Lucía Colodro Conde
International Research Network Development Meeting - Summary
Prenatal cannabis exposure and offspring neurodevelopment- Hanan El Marroun
Neonatal outcomes following self-reported cannabis use during pregnancy - Luke Grzeskowiak
Contextualizing the Potential Risks of Ondansetron Use in Pregnancy - Krista F Huybrechts,
Breakout session for midwives and other interested healthcare professionals
Improving HG Care - Dutch Speaker - Marjolein Houben
What do Service Users want? - Rebecca Painter
Dietary Information and Support - Marion McBride
Mental Health Information and Support - Michelle Nicholson
Improving HG Care - English Speaker - Ria Clarke
Fringe event for international charity and foundation development
10th - 11th October 2019
Amsterdam, Netherlands
Dr Rebecca Painter
Gynaecologist and fellow in fetal maternal medicine - University of Amsterdam
Patrick MM Bossuyt
Professor of Clinical Epidemiology
Dept. Clinical Epidemiology, Biostatistics & Bioinformatics
Amsterdam University Medical Centers
Caitlin Dean
Chair of Trustees, Pregnancy Sickness Support
PhD Student, University of Amsterdam
Marlena Fejzo
Professor of Research - UCLA, USC and HER Foundation
Iris Grooten
Registrar in obstetrics and gynaecology and PhD student - University of Amsterdam
Larissa Jansen
Junior doctor in obstetrics and gynaecology Franciscus Gasthuis
Researcher on core outcome set and definition of hyperemesis gravidarum at the University of Amsterdam
Cath Williamson
Professor of Women’s Health and Honorary Consultant in Obstetric Medicine at Guy’s and St Thomas’ and King’s College Hospitals.
Stephen O’Rahilly
Co-Director of the Wellcome Trust-MRC Institute of Metabolic Science (IMS) and Director of the MRC Metabolic Diseases Unit.
Aldo Maina
Internist, Ospedale Sant'Anna, in Torino.
Brian Cleary
Hanan El Marroun
Laila Tata
Associate Professor - University of Nottingham
Cath MacParlin
Anne Ostenfeld
MD, PhD student
Dept. of gynaecology and obstetrics North Zealand Hospital, Denmark
Linda Fiaschi
Senior Research Fellow in eHealth
Helen Penny
BSC(Hons), PhD, DClinPsy.
Charlotte Howden
Kimber Wakefield MacGibbon
Director - HER Foundation
Michelle Nicholson
Counsellor, Hyperemesis Counselling
Lucía Colodro Conde
Postdoctoral researcher at the Psychiatric Genetics laboratory at QIMR Berghofer Medical Research Institute in Brisbane (Australia)
Luke Grzeskowiak
Postdoctoral Research Fellow – Robinson Research Institute, University of Adelaide
Specialist Pharmacist – Women’s and Newborn health at Flinders Medical Centre
Affiliate Senior Research Fellow – South Australian Health and Medical Research Institute
Krista F. Huybrechts, MS, PhD
Associate Professor of Medicine at Harvard Medical School and an epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital.
Margaret O’Hara
Lone Holst